opentrade on 
↗
↗event6 outcomes
When will Intellia Therapeutics submit a BLA for Lonvo-z?
·Science and Technology·ends Apr 8, 2027vol cum
$3.2k
vol 24h
$0
outcomes
6
ends
Apr 8, 2027
outcomesclick to inspect →
showing 5 of 6
marketselected outcome
before April 2027
rank #1
United States
74¢
· 0.0pp
24h change
vol cum
$400
vol 24h
$0
spread
0.07
ends
Apr 8, 2027
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Apr 8, 2027
prices over time · before April 2027 highlighted
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWhen will the FDA approve Intellia Therapeutics' lonvo-z?
Before October 202750¢· 0.0ppBefore 202859¢· 0.0ppBefore July 202735¢· 0.0pp
$0 24h · 3 markets
polymarketFDA approves Daraxonrasib this year?
yes71¢· 0.0pp
$0 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢· 0.0pp
M0 24h · 1 market
kalshiWhen will Beam Therapeutics submit a BLA for Risto-cel?
before April 202780¢· 0.0ppbefore December54¢· 0.0ppbefore November47¢· 0.0pp
+3 others
$0 24h · 6 markets
polymarketFDA approves Retatrutide this year?
yes13¢· 0.0pp
$7 24h · 1 market
Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
yes70¢· 0.0pp
M0 24h · 1 market